Table 4 |
|||||||||||||
|
IC50s for chloroquine (CQ) quinine (QN), monodesethylamodiaquine (MdAQ) and artemisinin (ART) in nM. Geometric Least Squares Means Ratio between years. |
|||||||||||||
| MdAQ |
CQ |
QN |
ART |
||||||||||
|
|
|||||||||||||
| Variable |
2 one-sided 90% limits |
GLS Mean Ratio (%) |
90%CI |
2sided t p-value |
GLS Mean Ratio (%) |
90%CI |
2sided t p-value |
GLS Mean Ratio (%) |
90%CI |
2sided t-value |
GLS Mean Ratio (%) |
90%CI |
2sided t p-value |
|
|
|||||||||||||
| 1997 vs 2000 |
[80,125] |
516.7 |
[266.4,1002.3] |
<0.0001 |
63.2 |
[25.5,156.7] |
N.S. |
131.4 |
[69.3,249.2] |
N.S. |
166.8 |
[57.2,486.0] |
N.S. |
| 1997 vs 2001 |
[80,125] |
452.3 |
[230.3,888.2] |
<0.0001 |
113.5 |
[45.1,285.4] |
N.S. |
193.1 |
[103.8,359.2] |
0.005 |
110.9 |
[38.0,323.0] |
N.S. |
| 1997 vs 2002 |
[80,125] |
388.2 |
[209.6,719.2] |
<0.0001 |
71.3 |
[30.7,165.8] |
N.S. |
92.9 |
[52.1,165.4] |
N.S. |
110.8 |
[39.2,313.4] |
N.S. |
| 1997 vs 2003 |
[80,125] |
297.1 |
[154.0,573.0] |
<0.0001 |
86.2 |
[35.0,212.3] |
N.S. |
135.1 |
[73.9,247.2] |
N.S. |
175.6 |
[61.0,505.7] |
N.S. |
| 1997 vs 2004 |
[80,125] |
186.3 |
[106.1,326.9] |
0.003 |
88.0 |
[40.0,193.5] |
N.S. |
89.5 |
[52.8,151.6] |
N.S. |
172.5 |
[60.3,493.5] |
N.S. |
| 2000 vs 2001 |
[80,125] |
87.5 |
[42.5,180.4] |
N.S. |
179.6 |
[72.4,445.3] |
N.S. |
147.0 |
[73.3,294.9] |
N.S. |
66.5 |
[31.5,140.3] |
N.S. |
| 2000 vs 2002 |
[80,125] |
75.1 |
[38.5,146.7] |
N.S. |
112.9 |
[49.3,258.3] |
N.S. |
70.7 |
[36.6,136.5] |
N.S. |
66.4 |
[32.9,134.2] |
N.S. |
| 2000 vs 2003 |
[80,125] |
57.5 |
[28.4,116.5] |
N.S. |
136.4 |
[56.1,331.1] |
N.S. |
102.9 |
[52.0,203.3] |
N.S. |
105.3 |
[50.7,218.5] |
N.S. |
| 2000 vs 2004 |
[80,125] |
36.1 |
[19.4,67.0] |
<0.0001 |
139.2 |
[64.3,301.2] |
N.S. |
68.1 |
[36.8,125.9] |
N.S. |
103.4 |
[50.3,212.5] |
N.S. |
| 2001 vs 2002 |
[80,125] |
85.8 |
[43.4,169.6] |
N.S. |
62.8 |
[27.0,146.1] |
N.S. |
48.1 |
[25.4,91.1] |
0.002 |
100.0 |
[49.4,202.0] |
N.S. |
| 2001 vs 2003 |
[80,125] |
65.7 |
[32.0,134.7] |
N.S. |
75.9 |
[30.8,187.0] |
N.S. |
70.0 |
[36.0,135.8] |
N.S. |
158.4 |
[76.3,328.7] |
N.S. |
| 2001 vs 2004 |
[80,125] |
41.2 |
[21.9,77.5] |
0.000 |
77.5 |
[35.2,170.5] |
N.S. |
46.3 |
[25.6,83.9] |
<0.0001 |
155.6 |
[75.7,319.8] |
N.S. |
| 2002 vs 2003 |
[80,125] |
76.5 |
[39.4,148.6] |
N.S. |
120.8 |
[53.2,274.6] |
N.S. |
145.5 |
[78.0,271.2] |
N.S. |
158.5 |
[79.8,314.7] |
N.S. |
| 2002 vs 2004 |
[80,125] |
48.0 |
[27.1,84.8] |
<0.0001 |
123.3 |
[61.5,247.2] |
N.S. |
96.3 |
[55.7,166.8] |
N.S. |
155.7 |
[79.2,305.9] |
N.S. |
| 2003 vs 2004 |
[80,125] |
62.7 |
[33.9,115.8] |
N.S. |
102.1 |
[47.5,219.2] |
N.S. |
66.2 |
[37.2,117.9] |
N.S. |
98.2 |
[48.6,198.4] |
N.S. |
|
|
|||||||||||||
|
Vaillant and Olliaro Malaria Journal 2007 6:156 doi:10.1186/1475-2875-6-156 |
|||||||||||||